姓名:伍宇思
照片:
职称:讲师
研究生招生专业:药理学,护理学
电子邮箱:yusiwu@hunnu.edu.cn
通讯地址:湖南长沙岳麓区桐梓坡路371号,qm球盟会官方网站,410013
简介:
伍宇思,中南大学与加州大学洛杉矶分校联合培养博士,硕士生导师。湖南省健康管理学会肺血管病健康管理专业委员会委员。主要从事心血管药理学与血管疾病的机制与转化研究、慢病健康管理,在Hypertension、Redox Biology、European journal of Pharmacology等杂志发表SCI论文多篇,受邀担任Hypertension等杂志审稿人。
代表性学术论文:
(1)Yusi Wu#, Bingjie Pan#, Zhen Zhang, Xiaohui Li, Yiping Leng, Yong Ji, Kun Sun*, Alex F Chen*. Caspase-4/11-Mediated Pulmonary Artery Endothelial Cell Pyroptosis Contributes to Pulmonary Arterial Hypertension.Hypertension. 2022 Mar;79(3):536-548.
(2) Kai Huang#,Yusi Wu#, Yixuan Zhang, Ji Youn Youn, Hua Cai*. Combination of folic acid with nifedipine is completely effective in attenuating aortic aneurysm formation as a novel oral medication.Redox Biology. 2022 Dec;58:102521.
(3) Meiling Wang#,Yusi Wu#, Yanrong Yu, Yanqi Fu, Hang Yan, Xiaoying Wang, Tingting Li, Weijie Peng*, Dan Luo*. Rutaecarpine prevented ox-LDL-induced VSMCs dysfunction through inhibiting overexpression of connexin 43.European Journal Of Pharmacology. 2019 Jun 15;853:84-92.
(4) Ji Youn Youn#, Yixuan Zhang#,Yusi Wu, Maxime Cannesson, Hua Cai*. Therapeutic application of estrogen for COVID-19: Attenuation of SARS-CoV-2 spike protein and IL-6 stimulated, ACE2-dependent NOX2 activation, ROS production and MCP-1 upregulation in endothelial cells.Redox Biology. 2021 Oct;46:102099.
(5) Kai Huang#, Taro Narumi#, Yixuan Zhang, Qiang Li, Priya Murugesan,Yusi Wu,Norika Mengchia Liu, Hua Cai*. Targeting MicroRNA-192-5p, a Downstream Effector of NOXs (NADPH Oxidases), Reverses Endothelial DHFR (Dihydrofolate Reductase) Deficiency to Attenuate Abdominal Aortic Aneurysm Formation.Hypertension. 2021 Aug;78(2):282-293.
硕士生培养:
培养硕士研究生3名。